Therapy of scleroderma renal crisis: State of the art.

Abstract:

:Scleroderma renal crisis (SRC) is an uncommon but still life-threatening manifestation of systemic sclerosis (SSc). The incidence of SRC has decreased in the last few decades, probably due to a widespread use of vasodilators in SSc patients. It is well-recognized that exposure to different drugs can trigger SRC (corticosteroids, cyclosporine) or might prevent its occurrence (iloprost, calcium channel blockers). The prognosis of this life-threatening manifestation has not substantially improved since 1980s, when ACE-inhibitors were introduced in its treatment. ACE-inhibitors remain the mainstay in the therapy of SRC due to their efficacy in controlling malignant hypertension; indeed, the prognosis largely depends on the rapid improvement of the ongoing renal ischemia. Calcium-channel blockers and in third line diuretics and alpha-blockers should be used as additional therapy if blood pressure control remains suboptimal despite maximum tolerated doses of ACE-inhibitors. Given the growing evidence on the role of complement activation and endothelin-1 in the pathogenesis of SRC, recent case-series and case reports have suggested the use of C5-inhibitors and endothelin receptor antagonists in the therapy of SRC, mainly in the refractory cases. Plasma-exchange seems to give some benefits in patients with SRC and microangiopathy or intolerant to ACE-inhibitors. Renal transplantation is the last treatment option and its outcome is similar to that reported in other connective tissue disorders, with a 5-year patient survival rate of about 82%. In this review we summarize the current knowledge in the treatment of SRC.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Zanatta E,Polito P,Favaro M,Larosa M,Marson P,Cozzi F,Doria A

doi

10.1016/j.autrev.2018.03.012

subject

Has Abstract

pub_date

2018-09-01 00:00:00

pages

882-889

issue

9

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(18)30157-5

journal_volume

17

pub_type

杂志文章,评审
  • Autoimmune and proinflammatory activity of oxidized immunoglobulins.

    abstract:AIMS:Oxidation reactions can modify protein activity or specificity. Recently, a novel redox-reactive family of autoantibodies was described, which indicated involvement of altered antibodies (beside altered antigens) into autoimmune reactions. The aim of our study was to determine the binding capacity alterations of e...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2008.04.005

    authors: Omersel J,Jurgec I,Cucnik S,Kveder T,Rozman B,Sodin-Semrl S,Bozic B

    更新日期:2008-07-01 00:00:00

  • Treatment of rheumatic diseases in patients with HCV and HIV infection.

    abstract::A wide variety of rheumatic diseases has been documented in the presence of hepatitis C virus (HCV) infection and in human immunodeficiency virus (HIV) infection. In this conditions, physicians are refrained from using corticosteroids and/or immunosuppressants agents because of the risk of favouring viral replication ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.07.009

    authors: Galeazzi M,Giannitti C,Manganelli S,Benucci M,Scarpato S,Bazzani C,Caporali R,Sebastiani GD

    更新日期:2008-12-01 00:00:00

  • Childhood- versus Adult-Onset Polyarteritis Nodosa Results from the French Vasculitis Study Group Registry.

    abstract:OBJECTIVE:To investigate differences between childhood (cPAN)- and adult-onset polyarteritis nodosa (aPAN) patients. METHODS:cPAN patients' clinical findings at onset and outcomes were compared to those of aPAN patients from the French Vasculitis Study Group registry matched for year of enrollment and initial systemic...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.08.001

    authors: Iudici M,Quartier P,Pagnoux C,Merlin E,Agard C,Aouba A,Roblot P,Cohen P,Terrier B,Mouthon L,Guillevin L,Puéchal X,French Vasculitis Study Group.

    更新日期:2018-10-01 00:00:00

  • B cells in systemic sclerosis: a possible target for therapy.

    abstract::Systemic sclerosis (SSc) is an autoimmune disease characterized by excessive extracellular matrix (ECM) deposition in the skin and other visceral organs and it is associated with immune activation characterized by autoantibody production, release of various cytokines and T-lymphocyte activation. Several recent lines o...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.04.013

    authors: Bosello S,De Luca G,Tolusso B,Lama G,Angelucci C,Sica G,Ferraccioli G

    更新日期:2011-08-01 00:00:00

  • Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes.

    abstract:OBJECTIVE:To assess the effectiveness of anti-TNFalpha agents by analysing the principal clinical outcomes in patients with active rheumatoid arthritis (RA). METHODS:1010 patients who received no clinical benefit from previous treatment with methotrexate and/or other DMARDs, were subsequently treated with one or more ...

    journal_title:Autoimmunity reviews

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.autrev.2008.11.001

    authors: Bazzani C,Filippini M,Caporali R,Bobbio-Pallavicini F,Favalli EG,Marchesoni A,Atzeni F,Sarzi-Puttini P,Gorla R

    更新日期:2009-01-01 00:00:00

  • Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.

    abstract:OBJECTIVE:Low dose (10-25 mg/week) methotrexate is widely used for the management of systemic inflammatory diseases, and is considered to be relatively safe. Toxicity due to low dose MTX has been reported but is poorly characterized. We describe the clinical features, risk factors, and outcomes of low dose MTX toxicity...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.08.027

    authors: Kivity S,Zafrir Y,Loebstein R,Pauzner R,Mouallem M,Mayan H

    更新日期:2014-11-01 00:00:00

  • Gene therapy in autoimmune diseases: challenges and opportunities.

    abstract::Clinical treatment of autoimmune disorders presents a special challenge. For decades, most clinical regimens in autoimmunity has been largely symptomatic and non-disease specific. Although data from vigorous research has lead to accumulating knowledge on the pathogenic and immunological mechanisms of many autoimmune d...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.10.004

    authors: Leung PS,Dhirapong A,Wu PY,Tao MH

    更新日期:2010-01-01 00:00:00

  • Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity.

    abstract::Systemic lupus erythematosus (SLE) is a chronic immune-mediated inflammatory multisystem disease. The onset of viral and bacterial infections may favor the exacerbation of the disease, amplify autoimmune processes and contribute to mortality and morbidity. The prevention of influenza and Streptococcus pneumoniae infec...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.07.007

    authors: Murdaca G,Orsi A,Spanò F,Puppo F,Durando P,Icardi G,Ansaldi F

    更新日期:2014-02-01 00:00:00

  • Prevalence of cervical HPV infection in women with systemic lupus erythematosus: A systematic review and meta-analysis.

    abstract:OBJECTIVE:The objectives of this systematic review and meta-regression were: 1) to compare the prevalence of cervical HPV infection between SLE patients and healthy controls and 2) to evaluate the relationship between cervical HPV infection and traditional and SLE-related risk factors for cervical HPV infection in thes...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.autrev.2018.09.001

    authors: García-Carrasco M,Mendoza-Pinto C,Rojas-Villarraga A,Molano-González N,Vallejo-Ruiz V,Munguía-Realpozo P,Colombo AL,Cervera R

    更新日期:2019-02-01 00:00:00

  • Menopause in patients with autoimmune diseases.

    abstract::Menopause represents a time of significant clinical and hormonal change. Given the incompletely understood interrelationship between gonadal hormones and the immune system, it is possible that menopause may affect, or be affected by, the presence of autoimmune disease. Menopause has significant effects on a number of ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.006

    authors: Sammaritano LR

    更新日期:2012-05-01 00:00:00

  • Prednisone in lupus nephritis: how much is enough?

    abstract:OBJECTIVE:To assess the effectiveness and safety of a protocol using medium doses of prednisone to treat lupus nephritis. METHODS:Patients receiving the 'Cruces-protocol cohort' (CPC) were paired 1:2 with patients from the 'historic cohort' (HC). The CPC received medium doses of prednisone combined with methyl-prednis...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2013.10.013

    authors: Ruiz-Irastorza G,Danza A,Perales I,Villar I,Garcia M,Delgado S,Khamashta M

    更新日期:2014-02-01 00:00:00

  • Systemic sclerosis and infections.

    abstract::Systemic sclerosis (SSc) is an autoimmune disease characterized by vascular obliteration, excessive extracellular matrix deposition and fibrosis of the connective tissues of the skin, lungs, gastrointestinal tract, heart, and kidneys. Numerous infectious agents (bacterial and viral) have been proposed as possible trig...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.07.022

    authors: Randone SB,Guiducci S,Cerinic MM

    更新日期:2008-10-01 00:00:00

  • Autoinflammatory diseases: how to put the fire inside the body out?

    abstract::Autoinflammatory diseases (AIDs) are a group of distinct hereditable disorders characterized by unexplained, recurrent episodes of fever and severe inflammation, most commonly involving skin, joints, gut, and eyes. Mutations in inflammasome-related proteins, particularly in NOD-like receptor (NLR) genes, have been str...

    journal_title:Autoimmunity reviews

    pub_type:

    doi:10.1016/j.autrev.2012.07.013

    authors: Doria A,Dayer JM,Punzi L

    更新日期:2012-11-01 00:00:00

  • Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions.

    abstract::Regulatory T cells (Tregs) are central to the maintenance of self-tolerance and tissue homeostasis. Markers commonly used to define human Tregs in the research setting include high expression of CD25, FOXP3 positivity and low expression/negativity for CD127. Many other markers have been proposed, but none unequivocall...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.10.012

    authors: Grant CR,Liberal R,Mieli-Vergani G,Vergani D,Longhi MS

    更新日期:2015-02-01 00:00:00

  • Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura?

    abstract::Henoch-Schönlein purpura is the most common systemic vasculitis in childhood, characterized by the presence of immunoglobulin A deposits in the small vessels of skin, gastrointestinal tube, joints and kidneys. Although there have been great efforts made in elucidating its pathogenic mechanisms, Henoch-Schönlein purpur...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.04.003

    authors: Rigante D,Castellazzi L,Bosco A,Esposito S

    更新日期:2013-08-01 00:00:00

  • Improving the effectiveness of autoantibody testing in the clinic.

    abstract::To enable clinicians to use autoantibody tests sensibly and economically, laboratories providing the test service have a responsibility to supply the test 'specifications'. This should include information about the test's validity and reliability, its normal range or range within a control population, its sensitivity ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s1568-9972(02)00061-7

    authors: Sturgess A,Edmonds J

    更新日期:2002-10-01 00:00:00

  • Dysfunctional B cells in systemic lupus erythematosus.

    abstract::The classical view of B cells in the biology of autoimmune responses to infectious and self-antigens (Ag) that they promote immunity primarily by producing antibodies (Ab) is far from being complete. Indeed, studies over the last decade suggest that B cells have extraordinarily diverse functions within the immune syst...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2004.07.035

    authors: Renaudineau Y,Pers JO,Bendaoud B,Jamin C,Youinou P

    更新日期:2004-11-01 00:00:00

  • Incidence and nature of infectious disease in patients treated with anti-TNF agents.

    abstract::Tumor necrosis factor alpha (TNF-alpha) inhibitors offer a targeted therapeutic strategy that contrasts with the nonspecific immunosuppressive agents traditionally used to treat most inflammatory diseases. These biologic agents have had a significant impact in ameliorating the signs and symptoms of inflammatory rheuma...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.08.006

    authors: Raychaudhuri SP,Nguyen CT,Raychaudhuri SK,Gershwin ME

    更新日期:2009-12-01 00:00:00

  • Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies.

    abstract::Antiphospholipid syndrome is characterized with thrombotic events and/or pregnancy morbidity and antiphospholipid antibodies (aPL). The most common antigen for aPL is beta2-glycoprotein-I (beta(2)GPI), a plasma protein binding to negatively charged phospholipids. The influence of aPL on coagulation is not well underst...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.03.001

    authors: Ambrozic A,Cucnik S,Tomsic N,Urbanija J,Lokar M,Babnik B,Rozman B,Iglic A,Kralj-Iglic V

    更新日期:2006-11-01 00:00:00

  • 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.

    abstract::The 'Task Force on Catastrophic Antiphospholipid Syndrome (CAPS)' was developed on the occasion of the 14th International Congress on Antiphospholipid Antibodies. The objectives of this Task Force were to assess the current knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, prec...

    journal_title:Autoimmunity reviews

    pub_type:

    doi:10.1016/j.autrev.2014.03.002

    authors: Cervera R,Rodríguez-Pintó I,Colafrancesco S,Conti F,Valesini G,Rosário C,Agmon-Levin N,Shoenfeld Y,Ferrão C,Faria R,Vasconcelos C,Signorelli F,Espinosa G

    更新日期:2014-07-01 00:00:00

  • Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis.

    abstract::Sarcoidosis (SA) is a granulomatous disorder of an unknown etiology. Infectious, genetic factors and autoimmunity have been explored as potential causes of SA. Pathologic similarities between SA and tuberculosis (TB) suggest Mycobacterium tuberculosis, especially mycobacterial antigen(s) e.g. heat shock proteins (Mtb-...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.015

    authors: Dubaniewicz A

    更新日期:2010-04-01 00:00:00

  • Tools for critical appraisal of evidence in studies of diagnostic accuracy.

    abstract::Studies of accuracy are often more complex to understand than clinical trials, since there can be more than one outcome and scope (screening, diagnosis, and prognosis) and because results have to be reported in more than one way, than in clinical trials (relative risk or odds ratio). Sensitivity and specificity are co...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.autrev.2012.07.004

    authors: Giavarina D

    更新日期:2012-12-01 00:00:00

  • Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells.

    abstract::Analysis of autoantibodies (AAB) by indirect immunofluorescence (IIF) remains the hallmark of diagnosing autoimmune diseases despite the introduction of multiplex techniques. Non-organ specific AAB are screened in routine diagnostics by IIF on HEp-2 cells. However, IIF results vary due to objective (e.g., cell fixatio...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.02.033

    authors: Hiemann R,Büttner T,Krieger T,Roggenbuck D,Sack U,Conrad K

    更新日期:2009-09-01 00:00:00

  • Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia.

    abstract::Mixed cryoglobulinemia (MC) is an immunological disorder characterized by immune-complex-mediated systemic vasculitis involving small vessels, which may present with renal, cutaneous, rheumatologic, and/or neurological manifestations. Until recently, the possible appearance of anti-neuronal autoantibodies in periphera...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.07.027

    authors: Alpa M,Ferrero B,Cavallo R,Naretto C,Menegatti E,Di Simone D,Napoli F,La Grotta R,Rossi D,Baldovino S,Sena LM,Roccatello D

    更新日期:2008-10-01 00:00:00

  • Hemopoietic stem cell transplantation in rheumatic diseases--an update.

    abstract::Hematopoietic stem cell transplant (HSCT) for autoimmune diseases has been recognized as a potential treatment for patients who have failed conventional therapy. Autologous (self) donor cells have been preferred over allogeneic (HLA-matched) cells for rescue after high dose immunotherapy, given the previous higher rat...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.03.003

    authors: de Buys P,Khanna D,Furst DE

    更新日期:2005-09-01 00:00:00

  • Risk of scleroderma according to the type of immune checkpoint inhibitors.

    abstract:INTRODUCTION:Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs). Among them, ICIs-induced systemic sclerosis (SSc) is poorly known. METHODS:To better characterize this irAE, our comprehensive approach combined the description of ICIs-induced scleroderma cases, the systematic ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102596

    authors: Terrier B,Humbert S,Preta LH,Delage L,Razanamahery J,Laurent-Roussel S,Mestiri R,Beaudeau L,Legendre P,Goupil F,Hadjadj J,Stolzenberg MC,Treluyer JM,Westeel V,Valnet-Rabier MB,Wislez M,Mouthon L,Chouchana L

    更新日期:2020-08-01 00:00:00

  • Rhupus: a systematic literature review.

    abstract::"Rhupus" or "rhupus syndrome" is a poorly described and underdiagnosed disease in which features of both rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) appear in the same patient, most often sequentially. The SLE-related involvement is usually mild, dominated by hematological abnormalities and skin, ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102612

    authors: Antonini L,Le Mauff B,Marcelli C,Aouba A,de Boysson H

    更新日期:2020-09-01 00:00:00

  • Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.

    abstract::The presence of anti-nuclear antibodies (ANA) is a hallmark of systemic autoimmune rheumatic diseases (SARD). The indirect immunofluorescence (IIF) assay on HEp-2 cells is a commonly used test for the detection of ANA and was recently recommended as the screening test of choice by a task force of the American College ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.005

    authors: Mahler M,Hanly JG,Fritzler MJ

    更新日期:2012-07-01 00:00:00

  • Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?

    abstract::Autoimmune rheumatic diseases (ARD) are prevalent in women during their childbearing age. For their treatment, high doses of corticosteroid (CS) for long-term periods are often required, increasing the risk of bone loss. According to recent guidelines, bisphosphonates (BP) should be used as first line treatment to pre...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.03.002

    authors: Losada I,Sartori L,Di Gianantonio E,Zen M,Clementi M,Doria A

    更新日期:2010-06-01 00:00:00

  • Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM).

    abstract::Type 1 diabetes (T1DM) is an autoimmune disease with aberrant immune responses to specific β-cell autoantigens, resulting in insulin deficiency. Children and adolescents with T1DM may also develop organ-specific multiple autoimmunity in the context of APS (autoimmune polyendocrine syndrome) type 1, 2 or 3. The most fr...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.05.002

    authors: Kakleas K,Soldatou A,Karachaliou F,Karavanaki K

    更新日期:2015-09-01 00:00:00